Adjuvant palbociclib for ER+ breast cancer (PALLAS Trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13): A preplanned analysis of the stage IIA cohort Meeting Abstract
| Authors: | DeMichele, A.; Dueck, A. C.; Hlauschek, D.; Martin, M.; Burstein, H. J.; Pfeiler, G.; Zdenkowski, N.; Wolff, A. C.; Balic, M.; Miller, K.; Cameron, D. A.; Balko, J. M.; Traina, T. A.; Czajkowska, D.; Metzger, O.; Lu, D. R.; O'Brien, P.; Fesl, C.; Mayer, E. L.; Gnant, M.; PALLAS Trial Investigators |
| Abstract Title: | Adjuvant palbociclib for ER+ breast cancer (PALLAS Trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13): A preplanned analysis of the stage IIA cohort |
| Meeting Title: | 2022 ASCO Monthly Plenary Series |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 36 Suppl. |
| Meeting Dates: | 2022 Oct 18 |
| Meeting Location: | Online |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-10-20 |
| Start Page: | 390216 |
| Language: | English |
| DOI: | 10.1200/JCO.2022.40.36_suppl.390216 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 390216 -- Accession Number: 159797444 -- Entry Date: In Process -- Revision Date: 20221025 -- Publication Type: Article -- Supplement Title: 10/20/2022 Supplement 36 -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 8309333. -- Source: Cinahl |
